Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ataxin-8 Inhibitors

Ataxin-8 inhibitors are a class of chemical compounds designed to modulate the activity of the Ataxin-8 protein, which is known to be involved in RNA-binding processes and regulation of gene expression. Ataxin-8 is part of a broader family of ataxin proteins, some of which are implicated in the regulation of transcriptional processes and RNA stability. In particular, Ataxin-8 interacts with RNA and proteins within the cell to influence the function of various genetic pathways, especially those related to the maintenance of cellular homeostasis and response to stress. These interactions may affect the processing, transport, or degradation of RNA molecules, leading to downstream effects on cellular physiology.

Inhibitors of Ataxin-8 are typically small molecules that aim to disrupt its function by either blocking its RNA-binding domain or interfering with its interactions with other protein partners. By targeting these specific sites, inhibitors can affect the protein's ability to regulate RNA and gene expression. The development of Ataxin-8 inhibitors relies heavily on understanding the structure and function of the protein, including its RNA-binding motifs and domains critical for protein-protein interactions. Researchers use various techniques, such as molecular docking, biochemical assays, and structural biology methods like X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, to identify potential inhibitors. These compounds are refined through an iterative process, optimizing their ability to selectively bind to Ataxin-8 and disrupt its activity without affecting similar proteins in the cell. This approach helps ensure that the inhibitors achieve the desired specificity and efficacy in modulating Ataxin-8 function.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A inhibits histone deacetylases, which can lead to chromatin remodeling and downregulation of specific gene expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound inhibits DNA methyltransferases, potentially causing hypomethylation and the subsequent suppression of gene expression.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG108 blocks DNA methyltransferases, potentially leading to reduced methylation and lower gene expression levels.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$67.00
$306.00
2
(1)

Alsterpaullone inhibits cyclin-dependent kinases, which may result in cell cycle arrest and decreased gene expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA, inhibiting RNA polymerase and thus reducing mRNA synthesis and protein expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

This compound inhibits RNA polymerase II, which is crucial for mRNA transcription, thereby decreasing protein synthesis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Sirolimus inhibits mTOR, a kinase involved in the regulation of protein translation, potentially reducing protein synthesis.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$66.00
$153.00
16
(2)

17-AAG inhibits Hsp90, which is involved in proper folding and stability of many proteins, potentially decreasing their levels.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine raises endosomal pH, which can affect cellular signaling and transcription factors, potentially downregulating gene expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

This PI3K inhibitor can affect transcription factor activity and gene expression by altering the AKT signaling pathway.